Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of mood disorders: what clinicians need to know.

CNS spectrums - 1 Oct 2013

Laje Gonzalo

Abstract excerpt

Pharmacogenetics brought the promise of matching individuals with treatments that would be efficacious while minimizing adverse events. This has been long needed in psychiatry, where treatment options have been empirical and treatment choices have been made largely based on clinical judgment. The efficacy and tolerability of antidepressants, the most common drugs used in mood disorders, have been widely studied...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Cytochrome P-450 Enzyme System
Share to Genes, MDR

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mood Disorders

Share to Pharmacogenetics

Share to Receptor, Serotonin, 5-HT2A

Share to Serotonin Plasma Membrane Transport Proteins

Share to Treatment Outcome

Source

Identifiers

PMID: 24050155
DOI: 10.1017/S1092852913000278

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of mood disorders: what clinicians need to know.PMID 24050155Read ↗

Pharmacogenetic studies: a tool to improve antidepressant therapy.Semantic proximity Read ↗

Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics.Semantic proximity Read ↗

Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.Semantic proximity Read ↗

Pharmacogenetic considerations in the treatment of psychiatric disorders.Semantic proximity Read ↗

Pharmacogenetics: From Bench to ByteSemantic proximity Read ↗

[Pharmacogenetics in psychiatry: state of the art].Semantic proximity Read ↗

Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations.Semantic proximity Read ↗

Genetics of Treatment Outcomes in Major Depressive Disorder: Present and FutureSemantic proximity Read ↗

Pharmacogenetics and the pharmacological management of depression.Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.Semantic proximity Read ↗

Antidepressant pharmacogeneticsSemantic proximity Read ↗

A Narrative Review on Pharmacogenomics in Psychiatry: Scientific Definitions, Principles, and Practical Resources.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.